Beijing-Tianjin-Hebei Alliance Completes VBP Tender for Coronary Intervention Devices with 78.29% Price Cut
The Beijing-Tianjin-Hebei “3+N” allied region has completed a volume-based procurement (VBP) tender for coronary catheters,...
Policy / Regulatory
CDE Launches Guidelines to Expedite Pediatric and Rare Disease Drug Reviews
The Center for Drug Evaluation (CDE) has unveiled a new set of “Work Specifications to...
Round 8 VBP Tender Results Announced with RMB 21.6 Billion Market
The National Allied Procurement Office has issued an initial notification upon the completion of Round...
China’s NHSA Introduces Tiered Pricing for COVID-19 Therapies: A, B, and C Categories
The National Healthcare Security Administration (NHSA) has issued a Notification concerning the improvement of the...
NMPA Introduces Procedures to Adjust Chemical Generic Reference Preparations
The National Medical Products Administration (NMPA) has released a document outlining procedures for the adjustment...
National ADR Monitoring Report Highlights Oncology Drugs and Elderly Patient Safety
The National Center for ADR Monitoring has published its “National Adverse Drug Reaction Monitoring Annual...
China’s New Internet Advertising Regulations Impact Pharmaceutical Sector
The State Administration for Market Regulation has released the latest version of the “Measures for...
CDE Launches Technical Guidelines for Pediatric Anti-tumor Drug Development
The Center for Drug Evaluation (CDE) has released a set of Technical Guidelines focused on...
CDE Issues New Guidance on Pre-Phase III Clinical Trial Meetings for Innovative Drugs
The Center for Drug Evaluation (CDE) has released the “Innovative Chemical Drug Pre-Phase III Clinical...
CDE Launches Technical Guidelines for Pediatric Anti-tumor Drug Clinical R&D
The Center for Drug Evaluation (CDE) has released a set of Technical Guidelines focused on...
CDE Releases Guidance on Pre-Phase III Clinical Trial Meetings for Innovative Chemical Drugs
The Center for Drug Evaluation (CDE) has released the “Innovative Chemical Drug Pre-Phase III Clinical...
China’s Plan to Strengthen Medical and Healthcare Service System Unveiled
The General Office of the CPC Central Committee and State Council has released the “Opinions...
Beijing Initiates Volume-Based Procurement for Ophthalmology and Orthopedics Medical Consumables
The Beijing Municipal Medical Insurance Bureau has released a notification regarding the volume-based procurement (VBP)...
NMPA Releases 65th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 65th batch of reference drugs for...
NHSA Launches Crackdown on Medical Insurance Fund Management with New Inspection Measures
The National Healthcare Security Administration (NHSA) is intensifying efforts to manage medical insurance funds at...
CDE Issues Guidelines on Single-Arm Clinical Trials for Antitumor Drugs
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for the Applicability of...
NHSA’s 2022 Healthcare Security Bulletin Reveals Break-Even Performance
The National Healthcare Security Administration (NHSA) has released its annual “Healthcare Security Development Statistical Bulletin”...
NHSA’s 2022 Healthcare Security Report Reveals Break-Even Performance
The National Healthcare Security Administration (NHSA) has released its annual “Healthcare Security Development Statistical Bulletin”...
China’s Party and State Institutions Reshuffle: Key Changes for Healthcare and Finance
The second plenary session of the 20th Communist Party of China (CPC) Central Committee has...
Sunshine Medical Procurement Platform Announces VBP Tender Results for Yangtze River Delta
Shanghai’s Sunshine Medical Procurement All-In-One (SMPA) platform has revealed the resultant winning bids and spare...